Li Liangyu, Chen Jing, Ge Chao, Zhao Fangyu, Chen Taoyang, Tian Hua, Li Jinjun, Li Hong
Key Laboratory of Medical Molecular Virology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China,
Onco Targets Ther. 2019 Feb 28;12:1705-1716. doi: 10.2147/OTT.S196506. eCollection 2019.
CD24 is known as a heavily glycosylated cell surface molecule that is highly expressed in a wide variety of human malignancies. Previous studies have shown that CD24 plays an important role in self-renewal, proliferation, migration, invasion and drug resistance of hepatocellular carcinoma (HCC). However, little is known about the expression and function of CD24 isoform a (CD24A) and CD24 isoform b (CD24B) in HCC.
Quantitative real-time polymerase chain reaction (qPCR) and Western blotting were performed to detect CD24 and EGR1 expression in HCC cells and tissue. The function of CD24 in cell proliferation was verified with MTT assays, colony formation assays and tumor xenograft models. Wound healing assays and invasion assays were performed to clarify the function of CD24 in the regulation of cell migration and invasion in HCC. A dual luciferase reporter assay and chromatin immunoprecipitation assay were used to analyze the regulation mechanism of CD24A.
CD24A but not CD24B, which was barely detected by qPCR and Western blotting, is significantly upregulated in HCC tissue. Both CD24A and CD24B contribute to HCC cell proliferation, migration and invasion, but CD24A is more effective than CD24B. EGR1 downregulates CD24A and exerts transcription-promoting activity on the promoter. Furthermore, EGR1 represses HCC cell proliferation via downregulation of CD24A.
CD24A is the predominant CD24 isoform in HCC and plays a major role in cell proliferation, migration, and invasion. EGR1 can exert its antitumor effect through transcriptional downregulation of CD24A in HCC.
CD24是一种高度糖基化的细胞表面分子,在多种人类恶性肿瘤中高表达。先前的研究表明,CD24在肝细胞癌(HCC)的自我更新、增殖、迁移、侵袭和耐药性中起重要作用。然而,关于CD24异构体a(CD24A)和CD24异构体b(CD24B)在HCC中的表达和功能知之甚少。
采用定量实时聚合酶链反应(qPCR)和蛋白质免疫印迹法检测HCC细胞和组织中CD24和早期生长反应蛋白1(EGR1)的表达。通过MTT法、集落形成试验和肿瘤异种移植模型验证CD24在细胞增殖中的功能。进行伤口愈合试验和侵袭试验以阐明CD24在HCC细胞迁移和侵袭调节中的功能。采用双荧光素酶报告基因试验和染色质免疫沉淀试验分析CD24A的调控机制。
qPCR和蛋白质免疫印迹法几乎未检测到CD24B,而CD24A在HCC组织中显著上调。CD24A和CD24B均促进HCC细胞增殖、迁移和侵袭,但CD24A比CD24B更有效。EGR1下调CD24A并对其启动子发挥转录促进活性。此外,EGR1通过下调CD24A抑制HCC细胞增殖。
CD24A是HCC中主要的CD24异构体,在细胞增殖、迁移和侵袭中起主要作用。EGR1可通过转录下调HCC中的CD24A发挥其抗肿瘤作用。